OS Therapies Inc NYSE MKT LLC:OSTX
The leadership team, board of directors, and 10% beneficial owners of OS Therapies Inc, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
Acevedo Christopher P.
—109,375 sharesAuerbach Shalom
—23,371 sharesCiccio John
—20,000 sharesEinodmil LLC
—23,371 sharesGODDARD COLIN
—26,250 sharesMcKean-Dieser Avril Suzette
—5,000 sharesPETIT ROBERT
—200,000 sharesRomness Paul A.
—2,473,000 sharesSearch Theodore F.
—20,000 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.